{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:47:59Z","timestamp":1761486479233,"version":"3.30.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1006\/taap.2001.9297","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T22:01:25Z","timestamp":1032386485000},"page":"157-161","source":"Crossref","is-referenced-by-count":12,"title":["Electrophysiologic and Hemodynamic Effects of Apomorphine in Dogs"],"prefix":"10.1006","volume":"177","author":[{"given":"Hitomi","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A","family":"Carnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.Mark","family":"Strauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Hamlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/taap.2001.9297_RF1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00169260","article-title":"Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart","volume":"347","author":"Amenta","year":"1993","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1006\/taap.2001.9297_RF2","series-title":"Veterinary Pharmacology and Therapeutics","first-page":"1005","article-title":"Drugs affecting gastrointestinal function","author":"Boothe","year":"1995"},{"year":"1990","series-title":"Drug Dosage in Laboratory Animals\u2013A Handbook","author":"Borchard","key":"10.1006\/taap.2001.9297_RF3"},{"key":"10.1006\/taap.2001.9297_RF4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1536\/ihj.16.143","article-title":"Effect of apomorphine on the canine SA node","volume":"16","author":"Chiba","year":"1975","journal-title":"Jpn. Heart J."},{"key":"10.1006\/taap.2001.9297_RF5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0090-4295(00)00575-6","article-title":"Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The apomorphine study group","volume":"56","author":"Dula","year":"2000","journal-title":"Urology"},{"key":"10.1006\/taap.2001.9297_RF6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00002826-199304000-00008","article-title":"Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's disease","volume":"16","author":"Durif","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1006\/taap.2001.9297_RF7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-7258(99)00029-7","article-title":"Dopamine receptors: Physiological understanding to therapeutic intervention potential","volume":"84","author":"Emilien","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1006\/taap.2001.9297_RF8","first-page":"132","article-title":"Primate cardiovascular responses mediated by dopamine receptors: Effects of N,N-di-n-propyldopamine and LY171555","volume":"229","author":"Hahn","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/taap.2001.9297_RF9","first-page":"355","article-title":"Dose response and concentration response relationship of apomorphine in patients with Parkinson's disease and end-of-dose akinesia","volume":"36","author":"Harder","year":"1998","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1006\/taap.2001.9297_RF10","first-page":"153","article-title":"Cardiovascular autonomic dysfunction in Parkinsonian patients","volume":"5","author":"Mathias","year":"1998","journal-title":"Clin. Neurosci."},{"key":"10.1006\/taap.2001.9297_RF11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.1999.tb00399.x","article-title":"The deterioration of cardiovascular reflexes in Parkinson's disease","volume":"100","author":"Mesec","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1006\/taap.2001.9297_RF12","first-page":"92","article-title":"Studies on the cardiovascular actions of apomorphine in dogs: Central versus peripheral mechanisms and role of the adrenal medulla","volume":"277","author":"Montastruc","year":"1985","journal-title":"Arch. Int. Pharmacodyn."},{"key":"10.1006\/taap.2001.9297_RF13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-199937030-00004","article-title":"Pharmacokinetic\u2013pharmacodynamic relationships of apomorphine in patients with Parkinson's disease","volume":"37","author":"Neef","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1006\/taap.2001.9297_RF14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.2042-7158.1986.tb04462.x","article-title":"Concentration\u2013response relations for apomorphine effects on heart rate in conscious rats","volume":"38","author":"Paalzow","year":"1986","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1006\/taap.2001.9297_RF15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0031-6989(86)90030-5","article-title":"Evidence that dopamine receptors identified by [3H]dopamine in the ventricles of guinea-pig heart are of DA2 type","volume":"18","author":"Sandrini","year":"1986","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1006\/taap.2001.9297_RF16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2885.1990.tb00763.x","article-title":"Apomorphine-induced emesis in the dog-routes of administration, efficacy and synergism by naloxone","volume":"13","author":"Scherkl","year":"1990","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1006\/taap.2001.9297_RF17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/009127009903900506","article-title":"Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-h infusions in hypertensive patients: A dose-tolerability study","volume":"39","author":"Taylor","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1006\/taap.2001.9297_RF18","first-page":"159","article-title":"Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease","volume":"21","author":"van der Geest","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1006\/taap.2001.9297_RF19","first-page":"152","article-title":"Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's Disease","volume":"21","author":"Van Laar","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1006\/taap.2001.9297_RF20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI108522","article-title":"Hemodynamic determinants of the time-course of fall in canine left ventricular pressure","volume":"58","author":"Weiss","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1006\/taap.2001.9297_RF21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/toxsci\/51.2.273","article-title":"Evaluation of apomorphine HCl effects on reproductive endpoints: Studies in male rats and dogs","volume":"42","author":"Youssef","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1006\/taap.2001.9297_RF22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2460\/ajvr.1993.54.05.755","article-title":"Pharmacokinetics of propofol in mixed-breed dogs and Greyhounds","volume":"54","author":"Zoran","year":"1993","journal-title":"Am. J. Vet. Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X0199297X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X0199297X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T20:20:20Z","timestamp":1733170820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X0199297X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0041008X0199297X"],"URL":"https:\/\/doi.org\/10.1006\/taap.2001.9297","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}